header
Manya Angley
Research & Consulting

Refereed Publications
Journal Articles
Original Research

  1. Wang LV, Christophersen CT, Sorich MJ, Gerber, CP, Angley MT, Conlon MA, (2011) Low Relative Abundances of the Mucolytic Bacterium Akkermansia muciniphila and Bifidobacterium spp. in Feces of Children with Autism. Applied and Environmental Microbiology Vol. 77 (18) pp. p. 6718–6721, doi:10.1128/AEM.05212-11v [IF: 3.6].
  2. Wang LV,  Angley MT, Gerber CP, Sorich MJ,   A review of candidate urinary biomarkers for autism spectrum disorder. (In press) Biomarkers [IF: 1.7]
  3. Stafford L, Stafford A, Hughes, J, Angley MT, Bereznicki LRE, Peterson GM,  (2011) Drug-related problems identified in post-discharge medication reviews for patients taking warfarin. International Journal of Clinical Pharmacy DOI 10.1007/s11096-011-9515-0 [IF: 0.9]
  4. Angley M, Ponniah A, Spurling L, Sheridan L, Colley D, Nooney V, Bong XJ, Padhye V, Shakib S. (2011) Alternative pathways to post-discharge home medication reviews for high risk patients: Investigating feasibility and timeliness. Journal of Pharmacy Practice and Research vol. 41 no. 1 pp. 27-32. [No IF]
  5. Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, van Tienen EC, Angley MT, Bajorek, BV, McLachlan AJ, Mullan JR, Misan GM, Gaetani L, (2011) Clinical outcomes of a collaborative, home-based post-discharge warfarin management service. The Annals of Pharmacotherapy. 45: DOI 10.1345/aph.1P617 [IF:2.5].
  6. Wang LV, Angley MT, Sorich MJ, Young RL, McKinnon RA & Gerber JP, (2010) Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome? Autism Research. Vol.3 pp. 268–272, 2010 DOI: 10.1002/aur.145 [IF: 1.4].
  7. Main PAE, Angley MT, Thomas P, O’Doherty CE, Fenech M, (2010) ‘Folate/methionine metabolism and autism: a systematic review.’  American Journal of Clinical Nutrition. 91:1–26. [IF: 7.7]
  8. Yap IKS, Angley M, Veselkov K,  Holmes E, Lindon JC, Nicholson JK. (2010) Urinary metabolic phenotyping differentiates children with autism, from their unaffected siblings and age-matched controls.  Journal of Proteome Research Vol. 9 pp.  2996–3004 DOI: 10.1021/pr901188e [IF: 5.7]
  9. Haddy CA, Ward HM, Angley MT, McKinnon RA (2010) ‘Consumers’ Views of Pharmacogenetics – a qualitative study’ Research in Social and Administrative Pharmacy. vol. 6 no. 3 pp. 221 DOI Publications 10.1016/j.sapharm.2009.08.002 [IF: 0.7]
  10. Lane A, Young R, Baker A,  Angley M, (2010) ‘Sensory processing subtypes in autism: association with adaptive behavior’. Journal of Autism and Developmental Disorders. Vol. 40, pp. 112–122. DOI 10.1007/s10803-009-0840-2 [IF: 4.4]
  11. Wang LV, Angley MT, Gerber JP, Young RL, Abarno DV, McKinnon RA & Sorich MJ, (2009) Is Urinary Indolyl-3-Acryloylglycine (IAG) a Biomarker for Autism with Gastrointestinal Symptoms? Biomarkers. Vol: 14, pp 596-603 DOI 10.1080/13547500903183962 [IF: 1.7]
  12. Lövgren S, Clark RA, Angley M, Ponniah AP, Colley D, Shakib S, (2009) ‘Timeliness and Clinical Impact of Hospital-Initiated Medication Reviews’ Journal of Pharmacy Practice and Research vol. 39 no. 4 pp. 269-273 [No IF]
  13. Vasileff H, Whitten L, Pink J, Goldsworthy S, & Angley M, (2009) ‘The effect on medication errors of pharmacists charting medications in an Emergency Department' Pharmacy World & Science vol.31: pp373-379  [IF: 0.9]
  14. Leong EM, Semple SJ, Angley MT, Siebert WJ, Petkov JP, & McKinnon RA, (2009) Complementary and alternative medicines in multiple sclerosis: What is being used in Australia and why? (2009) Complementary Therapies in Medicine vol. 17, pp. 216—223 [IF: 2.1]
  15. Bollella G, Angley M, Pink J, Caird C & Goldsworthy S. (2008) ‘A randomised controlled trial to determine the optimal level of Liaison Pharmacist intervention to facilitate a post-discharge Home Medicines Review.’ Journal of Pharmacy Practice and Research vol. 38 no.2 pp.107-110. [No IF]
  16. Grzeskowiak L, Ellis D, Phillips A & Angley M (2008) ‘Implementation of a chart and guidelines for monitoring physical health and adverse effects in children and adolescents prescribed antipsychotics.’ Journal of Pharmacy Practice and Research vol. 38 no.1 pp.9-13. [No IF]
  17. Ponniah A, Shakib S, Doecke C, Boyce M & Angley M (2008) ‘Post-discharge medication reviews for patients with heart failure: a pilot study.’ Pharmacy World & Science, vol. 30 pp. 810-815  [IF: 0.9]
  18. Baker A, Lane A, Angley M & Young R. (2008) ‘The Relationship Between Sensory Processing Patterns and Behavioural Responsiveness in Autistic Disorder: a Pilot Study, Journal of Autism and Developmental Disorders.vol. 38 pp. 867–875 [IF: 4.4]
  19. Ajdukovic M, Crook M, Angley C, Stupans I, Soulsby N, Doecke C, Anderson B & Angley M, (2007) ‘Pharmacist elicited medication histories in the Emergency Department: Identifying patient groups at risk of medication misadventure.’ Pharmacy Practice vol. 5 no. 4 pp.162-168. [No IF]
  20. Nguyen A, Yu K, Shakib S, Doecke C, Boyce M, March G, Anderson B, Gilbert A & Angley M, (2007) ‘Classification of findings in the Home Medicines Review reports of Post-Discharge Patients at risk of Medication Misadventure.’ Journal of Pharmacy Practice and Research vol. 37 no. 2 pp. 111-114. [No IF]
  21. Yu K, Nguyen A, Shakib S, Doecke C, Boyce M, March G, Anderson B, Gilbert A & Angley M, (2007) ‘Enhancing Continuity of Care: Development of a post-discharge Home Medicines Review Model’.Journal of Pharmacy Practice and Research vol. 37 no. 1 pp.22-26. [No IF]
  22. Ponniah A, Anderson B, Shakib S, Doecke C and Angley M, (2007) ‘Pharmacists' role in the post-discharge management of patients with heart failure - a literature review.’ Journal of Clinical Pharmacy and Therapeutics vol. 32, no. 4, pp 343-352 [IF: 1.7]
  23. Crook M, Ajdukovic M, Angley C, Soulsby N, Doecke C, Stupans I & Angley M, (2007) ‘Eliciting comprehensive medication histories in the emergency department: the role of the pharmacist.’ Pharmacy Practice vol. 5 no. 2 pp.78-84. [No IF]
  24. Stupans I, Angley M, March G & Soulsby N, (2005) ‘Graduate Qualities: Exploring Problem Solving in the Applied Pharmacotherapeutics Curriculum at the University of South Australia.’ Pharmacy Education. vol. 5 pp. 261-265. [No IF]
  25. Angley MT, Sansom LN, Smeaton TC & Stupans I. (1996) ‘The effects of cyclophosphamide on the pharmacokinetics of triiodothyronine in the male rat’ Journal of Pharmacy and Pharmacology. vol. 48 pp. 386-389. [IF: 1.9]
  26. Angley MT, Sansom LN and Stupans I. (1995) ‘Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat; its effects on hepatic and pulmonary cytochrome P450 and associated enzymes’ Xenobiotica.  Vol. 25 pp.1051-1062 [IF: 2.8]
  27. McClure MT & Stupans I. (1995) ‘Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamide’ Biochemical Pharmacology.   vol. 49 pp.1827-1836 [IF: 4.3]
  28. Stupans I, Richards DA & McClure MT. (1995) ‘The effects of 5-fluorouracil treatment on rat liver microsomal enzymes’ Xenobiotica. vol. 25 pp. 1-8 [IF: 2.8]
  29. McClure MT & Stupans I. (1992) ‘Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats’. Biochemical Pharmacology. vol. 43 pp. 2655-2658. [IF: 4.3]

Opinion piece

  1. Angley M, Ellis D, Chan W, Young R, McKinnon R, (2007) ‘Children and autism: Part 1 - recognition and pharmacological management.’ Australian Family Physician vol. 36 no. 9 pp. 741-744. [IF: 0.6]
  2. Angley M, Semple S, Paterson F, Hewton C, McKinnon R, (2007) ‘Children and autism: Part 2 - management with complementary medicines and dietary interventions.’ Australian Family Physician vol. 36 no. 10 pp. 827-830. [IF: 0.6]

Letter to the editor

  1. Ellis D, Shirzadi K, Grzeskowiak L & Angley M (2008) ‘Development of a novel program to facilitate monitoring physical health and adverse effects in children and adolescents prescribed antipsychotic medication.’ Australasian Psychiatry. Vol 16 no.2 pp 368-369. [No IF]

Books / Book Chapters

  1. Semple S, Hewton C, Paterson F, Angley M (2011). Complementary Medicine Products Used in Autism - Evidence for Rationale, Autism Spectrum Disorders - From Genes to Environment, Tim Williams (Ed.), ISBN: 978-953-307-558-7, InTech,  Available from: http://www.intechopen.com/articles/show/title/complementary-medicine-products-used-in-autism-evidence-for-rationale
  2. Semple S, Hewton C, Paterson F, Angley M (2011). Complementary Medicine Products Used in Autism - Evidence for Efficacy and Safety, Autism Spectrum Disorders - From Genes to Environment, Tim Williams (Ed.), ISBN: 978-953-307-558-7, InTech,  Available from: http://www.intechopen.com/articles/show/title/complementary-medicine-products-used-in-autism-evidence-for-efficacy-and-safety
  3. Australian Medicines Handbook, Associate Editor. 2001
  4. Australian Medicines Handbook, Associate Editor. 2002

Reports

  1. Peterson, Jackson S, Bereznicki L, Nelson M, Angley M, Mullan J, Gaetani L, Misan G,  Marsden K, Warburton P, Eaton V, Shakib S, Maddison J, Doecke C, Mangoni A, Yeo W, Potter J, Seaton S, Gee P, Fitzmaurice K, Stafford L, van Tienen E, Hill G, DeBoos I, Doran C, Jainullabudeen T (2010)  'The role of community pharmacy in post discharge management of patients initiated on warfarin' A report submitted to  the Department of Health and Ageing.
    http://beta.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Funded_Projects/Fourth_Community_
    Pharamcy_Agreement/RFT0804%20Executive%20Summary%20FINAL.pdf
  2. Angley M, Ponniah A, Bong XJ, Padhye V,  Shakib S, Spurling L.  (2010) ‘Implementing and Evaluating a Parallel Post-discharge Home Medicines Review (HMR) Model.’ A report prepared for the Department of Health and Ageing.
    http://www.guild.org.au/sites/The_Guild/tab-Pharmacy_Services_and_Programs/Research_and_Development/Fourth%
    %20Agreement/IIG-011.page
  3. Angley M, Gilbert A, Roughead L, Mott K, Semple S. (2008) Quality Use of medicines in Arthritis and Osteoporosis. A report prepared for the Department of Health and Ageing.

 

Non- Refereed Publications
Journal Articles
Opinion piece

  1. Angley M, McKinnon R, Young R, Evans A. ‘Autism and children: Can the pharmacist help?’ Australian Pharmacist 25(6):468-472 (2006)
  2. Lim, Y.Z., Angley, M Tait, P., Young, R. & McKinnon, R. (2006).  ‘Immunisation and autism: Sifting myth from reality?’ Australian Pharmacist vol. 25 no. 7 pp. 554-558.
  3. Angley MT, Gilbert AL, March GJ, Edgecombe SM & Hocking PN. (1997) ‘Community Pharmacy Model Practices Project’ Australian Pharmacist. vol. 16, no. 1 pp. 40-44.
  4. March GJ, Gilbert AL, Angley MT, Edgecombe SM, Hocking PN & Gilbert H. (1997) ‘Diabetes Care Model: Pharmaceutical Care Services for People with Diabetes’ Australian Pharmacist. vol. 16 no. 3 pp.156-158.
  5. Angley MT, Gilbert AL, March GJ, Edgecombe SM & Hocking PN. (1997) ‘Medication Management Model’ Australian Pharmacist.  vol. 16 no. 7 pp. 415-418.

Website

  1. Grzeskowiak L, Ellis D, Phillips A & Angley M ‘CYWHS Antipsychotic Physical Health and Adverse Effect Monitoring Package’’ http://www.wch.sa.gov.au/services/az/other/pharmacy/antipsychotic.html

Booklet

  1. Lim YZ, Young, R, Tait, P, McKinnon R & Angley M ‘Autism and Immunisation: The story behind the controversy’ A guide for parents. 2005. Free booklet to download

Full papers in conference proceedings

  1. Angley M, Hewton C, Paterson F, Semple S, Ellis D,  Chan W, Grzeskowiak L, Shirzadi K, Phillips A, Stanek J, (2007) Quality use of conventional and complementary medicines in autism. 8th International Congress Autism Europe.Oslo.

 

Conference presentations

Key Note Symposia
International

  1. Angley M, Semple S, Hewton C, Paterson F and Lim HK (2009) ‘Making sense of complementary and alternative medicine use in autism’ Asia Pacific Autism Conference (APAC) Sydney, Australia. (Registration, dinner and accommodation covered by organisers)

National

  1. Angley M, Ponniah A, Bong XJ, Spurling L, Padhye V, Sheridan L, Colley D, Nooney V, Shakib S. Implementation of a novel post discharge medication review model: making sense of outcomes to inform policy and practice. Pharmacy Practice Summit 2010, Canberra. (Registration, travel and accommodation paid for by conference organisers).
  2. Ponniah A, Shakib S, Spurling L, Sheridan L, Colley D, Nooney V,  Bong XJ, Padhye V, Angley M. Alternative pathways to post discharge medication reviews: a trial to inform policy and practice. Pharmacy Practice Summit 2010, Canberra. (Registration, travel and accommodation paid for by conference organisers).
  3. Angley M, Padhye V, Ponniah A, Spurling L, Bong XJ, Sheridan L, Colley D, Nooney V, Shakib S. What’s in, what’s out? Health professionals’ experiences with implementation of a novel post discharge medication review model. Pharmacy Practice Summit 2010, Canberra. (Registration, travel and accommodation paid for by conference organisers).
  4. Angley M, Spurling L, Shakib S, Ponniah A. (Sept 2008) ‘Medication management; examining the evidence’ at the COSP seminar, Medicines Management in Australia: what is the evidence and future direction, SHPA Federal Conference, Adelaide. (Registration covered by organisers)
  5. Angley M, Semple S and O’Keefe M, (May 2008) ‘Complementary and Alternative Medicine use in Childhood Autism’ (May 2008) In proceedings of the Royal Australasian College of Physicians National Congress, Adelaide. (Registration covered by organisers)
  6. Angley M (Aug 2007) ‘Bridging the gap-issues with continuity of care.’ Pharmacy Australia Congress (PAC), Melbourne. (Accommodation, flights and honorarium covered by organisers)
  7. Angley M (Aug 2007) ‘Monitoring adverse effects in children and adolescents prescribed antipsychotics; Why and how.’ Pharmacy Australia Congress (PAC), Melbourne. (Accommodation, flights and honorarium covered by organisers)
  8. Angley M,  Ellis D,  Chan W, Grzeskowiak L, Shirzadi K, Phillips A, Stanek J, (Dec 2006) ‘Quality use of antipsychotic medications in children and adolescents.’ Australasian Pharmaceutical Sciences Association New Investigator’s Symposia In proceedings of the Australasian Pharmaceutical Sciences Association Meeting, Adelaide.

Local

  1. Angley M, (May 2009) ‘Complementary Medicines’, Insights and Innovations, In proceedings of the Autism SA 3rd State Conference, Adelaide. (Registration covered by organisers)
  2. Angley M (Nov, 2007) ‘The hard road isn’t always the wrong road’ Healthy Development Adelaide Career Development Event: Forging a research career when the going gets tough
  3. Angley M & Semple S, (May 2007) ‘Quality Use of Medicines in autism and developing a metabonomic based laboratory test to diagnose autism.’ In proceedings of the Autism SA 2nd State Conference, Adelaide.
  4. Angley MT Shakib S and Boyce M (May, 2006). ‘The Power of Partnerships’ Presented at ‘The strength is in the network’ Annual State Divisions Conference, Adelaide
  5. Angley M (Nov, 2006) ‘Quality use of antipsychotic medications in children and adolescents: optimising prescribing, continuity of care and monitoring for adverse effects’ Healthy Development Adelaide Mental Health Event: Nipping Mental Illness in the Bud, Adelaide.
  6. Angley MT, Ellis D and McKinnon RA (May, 2005). ‘Autism Research at the University of South Australia.’ In Proceedings of the Inaugural Autism SA State Conference, Adelaide (Registration paid by organisers)

 
footer